Capstone Therapeutics: reports an executive or board change, makes a Regulation FD disclosure and discloses other events
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001171843-11-002981
- Document
- 8-K
- Reports an executive or board change (5.02)
- Makes a Regulation FD disclosure (7.01)
- Discloses other events (8.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 5030 and related industry codes: the same peer list as the financial tables.
- Aspen Aerogels ASPN public float $480M, Jun 30, 2025
- Olenox Industries OLOX public float $8M, Jun 30, 2026
- Boise Cascade BCC public float $3.2B, Jun 30, 2025
- QXO QXO public float $13.7B, Jun 30, 2025
- SMJ International Holdings SMJF
